Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/04/2007WO2007054770A3 Pyrazole derivatives and their medical use
10/04/2007WO2007054100A3 Lna nucleoside phosphoramidates
10/04/2007WO2007053684A3 Neuroprotective agents
10/04/2007WO2007052157A3 Depigmenting composition for the skin, comprising adapalene, at least one depigmenting agent and at least one anti-inflammatory agent
10/04/2007WO2007052152A3 Sertraline oral concentrate
10/04/2007WO2007051468A3 Preparation of an antibiotic crystalline fusidic acid
10/04/2007WO2007050510A3 Hiv integrase inhibitors
10/04/2007WO2007050348A3 Potassium channel inhibitors
10/04/2007WO2007050178A3 Skin care composition for accelerated production of collagen proteins and method of fabricating same
10/04/2007WO2007049158A3 Ppar modulating biaromatic compounds
10/04/2007WO2007049137A3 Canola extracts containing high levels of sinapic acid
10/04/2007WO2007049098A3 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/04/2007WO2007047623A3 Methods of inhibiting cell growth and methods of enhancing radiation responses
10/04/2007WO2007047591A3 Cetp inhibitors
10/04/2007WO2007047501A3 Outer membrane vesicles: novel vaccine for gram-negative biothreat agents
10/04/2007WO2007045982A3 Use of collagen in combination with oxygen- and ozonereleasing perfluorocarbons for the preparation of a medicament for the treatment of skin lesions
10/04/2007WO2007044251A3 Pharmaceutical compositions
10/04/2007WO2007041278A3 Composition and methods for stimulating gastrointestinal motility
10/04/2007WO2007039201A3 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis
10/04/2007WO2007038325A3 Indanylamines and their use for local anesthesia and chronic pain
10/04/2007WO2007035771A3 Modulation of glucagon receptor expression
10/04/2007WO2007035678A3 Methods of identifying agents having antiangiogenic activity
10/04/2007WO2007035620A3 Carbazole derivatives
10/04/2007WO2007035489A3 Methods of treating or preventing cancer using pyridine carboxaldehyde pyridine thiosemicarbazone radiosensitizing agents
10/04/2007WO2007033356A3 Compositions and methods for green tea catechins for modification of detoxification enzymes
10/04/2007WO2007033214A3 Esters of compounds in the leptomycin family
10/04/2007WO2007031879A3 Lipid a analogs for treating oral and gastrointestinal mucositis
10/04/2007WO2007027565A3 Argatroban formulation comprising an acid as solubilizer
10/04/2007WO2007026246A3 Synapse-specific proteins in glomeruli
10/04/2007WO2007025261A3 Non-irritating solvent-borne polymeric coatings for application to the skin
10/04/2007WO2007025177A3 Neurogenesis by muscarinic receptor modulation
10/04/2007WO2007022541A3 Method of treating dry eye disease with non-drying antihistamines
10/04/2007WO2007022351A3 Muscarinic acetylcholine receptor antagonists
10/04/2007WO2007022076A3 Prevention of neurodegeneration by macrolide antibiotics
10/04/2007WO2007021610A3 Ribonucleoside cyclic acetal derivatives for the treatment of rna-dependent rna viral infection
10/04/2007WO2007016538A3 Preparation and use of biphenyl amino acid derivatives for the treatment of obesity
10/04/2007WO2007016190A3 Antiparkinsonian action of phenylisopropylamines
10/04/2007WO2007015170A3 Synapse-specific proteins in glomeruli
10/04/2007WO2007014894A3 Glucopyranosyl-substituted ( (hetero) cycloalyklethynyl-benzyl) -benzene derivatives and use thereof as sodium-dependent glucose cotransporter (sglt) inhibitors
10/04/2007WO2007014124A3 High drug load formulations and dosage forms
10/04/2007WO2007007207A8 Pharmaceutical compositions of 3, 5 -bis (arylidene) -4 -piperidones and analogues there of for modulating cell proliferation
10/04/2007WO2007002842A3 Substituted n-cinnamyl benzamides
10/04/2007WO2007001348A3 Heteroaryl-containing isoflavones as aromatase inhibitors
10/04/2007WO2006135445A3 Antimicrobial chelates
10/04/2007WO2006131836A3 Compounds and compositions for use in the prevention and treatment of obesity and related syndromes
10/04/2007WO2006107771A3 PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS
10/04/2007WO2006100588A8 Substituted triazole derivatives as oxytocin antagonists
10/04/2007WO2006099258A8 Tigecycline compositions and methods of preparation
10/04/2007WO2006089009A8 Methods and compositions for the treatment of lipid-associated disorders
10/04/2007WO2006084191A3 Local gene therapy with an eluting stent for vascular injury
10/04/2007WO2006084174A3 Improved bioavailability and improved delivery of alkaline pharmaceutical drugs
10/04/2007WO2006083458A3 Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions
10/04/2007WO2006078331A3 Crystallization via high-shear transformation
10/04/2007WO2006074455A3 Method for transformation of conventional and commercially important polymers into durable and rechargeable antimicrobial polymeric materials
10/04/2007WO2006072259A3 Taurine synthesis, production and utility as a medicine
10/04/2007WO2006060172A3 Methods for identifying graft rejection suppressing compounds
10/04/2007WO2006037105A3 Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof
10/04/2007WO2006030306A8 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
10/04/2007WO2005060694A3 Treatment of neurologic disorders with inhibitors of 11beta-hsd1
10/04/2007WO2005039546A3 Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
10/04/2007WO2005032462A3 Glucocerebroside treatment of disease
10/04/2007WO2005030133A3 Treatment with agonists of toll-like receptors
10/04/2007WO2005016239A3 Molecules enhancing dermal delivery of influenza vaccines
10/04/2007US20070232819 Has af-bis(acetato)-b-(1-adamantylamine)-c-ammine-de-dichloroplatinum(IV) complex; stable, can be easily prepared and its composition is simple
10/04/2007US20070232798 Process For The Synthesis Of 2'-O-Substituted Pyrimidines And Oligomeric Compounds Therefrom
10/04/2007US20070232796 Medical Solution, a Method for Producing Said Medical Solution and Use Thereof
10/04/2007US20070232703 food contains honokiol active drug known having activity to inhibit bone resorption, for treating bone disorders like bone fracture, stress fracture, pre-osteoporosis disease, osteoporosis, hypercalcemia, hyperparathormone disease, Paget's disease, arthritis, rheumatism, metastasis of breast cancer
10/04/2007US20070232702 Methods and Compounds for Detection of Medical Disorders
10/04/2007US20070232701 Synergistic compositions useful as cytostatic, bacteriostatic and/or virostatic agents
10/04/2007US20070232700 Use of rasagilline for the treatment of restless legs syndrome
10/04/2007US20070232699 N-(10,12-pentacosadiynoyl)-N',N'-diethylethylenediamine hydrobromide; amphiphilic diacetylene compounds having a bilayer-compatible hydrophobic chain; acetylenic homopolymers; microbiocides; nanostructures such as nanocarpets; uniform dimensions; biosensors; optics; electronics; drugs
10/04/2007US20070232698 Slimming Skin External Preparation and Cosmetic Containing the Same
10/04/2007US20070232697 Method for preparing free base compositions and formulations thereof
10/04/2007US20070232696 Valproic acid and derivatives thereof as histone deacetylase inhibitors
10/04/2007US20070232695 Has a high concentration of topical anesthetic (tetracaine, benzocaine, butamben) carried in a non-aqueous liquid vehicle containing a gelling agent
10/04/2007US20070232692 Method of Treating Cancer Using Dithiocarbamate Derivatives
10/04/2007US20070232691 Use of ladostigil for the treatment of schizophrenia
10/04/2007US20070232690 Composition for inducing differentiation of leukemic cells and application thereof
10/04/2007US20070232689 3-ethyl-4-[[2-(1-oxaspiro[4.4]non-6-ylamino)-3,4-dioxo-1-cyclobutene-1-yl]amino]-benzonitrile; urinary incontinence, overactive bladder, hypertension, sexual disorders, dysmenorrhea, irritable bowl syndrome, epilepsy, stroke, Alzheimer's and Parkinson's, hair loss
10/04/2007US20070232688 Novel sterol/stanol phosphorylnitroderivatives and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
10/04/2007US20070232687 Agent for Skin External Use Containing Tocopherol Derivative, Ascorbic Acid Derivative and Surface Active Agent Having Lipopeptide Structure
10/04/2007US20070232686 Cyanoamidine P2X7 Antagonists for the Treatment of Pain
10/04/2007US20070232685 Crystalline forms of n-(benzo[b]thien-3-ylmethyl)-sulfamide
10/04/2007US20070232684 Compounds for inhibition of HIV infection by blocking HIV entry
10/04/2007US20070232683 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof
10/04/2007US20070232682 Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist
10/04/2007US20070232681 Compounds Having Crth2 Antagonist Activity
10/04/2007US20070232680 Preparation of ramipril and stable pharmaceutical compositions
10/04/2007US20070232679 N-Aryl Pyrrolidine Derivatives as Beta-Secretase Inhibitors
10/04/2007US20070232678 (4, 5, 6, 7-Tetrahydro-1-H-Indol-7-Yl) Acetic Acid Derivatives for Treatment of Alzheimer's Disease
10/04/2007US20070232677 Treatment and prevention of vascular hyperplasia using polyamine and polyamine analog compounds
10/04/2007US20070232675 Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
10/04/2007US20070232674 treating gram negative bacterial infection or sepsis by neutralizing lipopolysaccharides
10/04/2007US20070232673 2-Imino-benzimidazoles
10/04/2007US20070232672 Pharmaceutical Composition And Method For Treating Neurodegenerative Disorders
10/04/2007US20070232671 Methods and compositions for treatment of diastolic heart failure
10/04/2007US20070232669 N-phenylbenzotriazolyl c-kit inhibitors
10/04/2007US20070232668 Orally Bioavailable Caffeic Acid Related Anticancer Drugs
10/04/2007US20070232667 Methods for Treating Hyperlipidemia With Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics
10/04/2007US20070232666 Novel Chromen-2-One Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
1 ... 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 3568 3569 3570 3571 3572 3573 3574 3575 3576 ... 7860